Charles River Laboratories International's EBIT per Share for the
three
months ended in Mar. 2026 was €-0.06.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €-1.02.
During the past 12 months, the average EBIT per Share Growth Rate of Charles River Laboratories International was 19.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -13.90% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -3.40% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 8.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
MIL:1CRL'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -15.9 Med: 9.8 Max: 21.5
Current: -13.9
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Charles River Laboratories International was 21.50% per year. The lowest was -15.90% per year. And the median was 9.80% per year.
MIL:1CRL's 3-Year EBIT Growth Rate is ranked worse than 78.44% of 167
companies
in the Medical Diagnostics & Research industry
Industry Median: 13.2
vs MIL:1CRL: -13.90
Charles River Laboratories International (MIL:1CRL) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Charles River Laboratories International EBIT per Share Related Terms
Charles River Laboratories International EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International EBIT per Share Chart
Charles River Laboratories International Annual Data
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International (MIL:1CRL) has a EBIT per Share of €-1.02 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Charles River Laboratories International and its competitors. According to the industry distribution chart, Charles River Laboratories International ranks #131 out of 167 companies in the Medical Diagnostics & Research industry, placing it in the top 78.4%.
Is Charles River Laboratories International's EBIT per Share too high?
Charles River Laboratories International's current EBIT per Share is €-1.02. Based on the distribution chart, Charles River Laboratories International ranks #131 out of 167 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Charles River Laboratories International has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's EBIT per Share compare to RVTY and QGEN?
According to the Medical Diagnostics & Research industry distribution chart, Charles River Laboratories International ranks #131 out of 167 companies for EBIT per Share. This places Charles River Laboratories International in the lower half of its industry. The industry median EBIT per Share is 13.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Diagnostics & Research company?
The median EBIT per Share among Medical Diagnostics & Research companies is 13.20, based on 167 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Charles River Laboratories International and its competitors. For the Medical Diagnostics & Research industry, the median EBIT per Share is 13.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Charles River Laboratories International's current EBIT per Share is €-1.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Charles River Laboratories International (MIL:1CRL) has a current EBIT per Share of €-1.02. The stock's GF Value™ is €124.86, compared to a current price of €143.90 — trading 15.2% above its estimated fair value. The current EBIT per Share is €-1.02. Charles River Laboratories International's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Charles River Laboratories International (MIL:1CRL), the current EBIT per Share is €-1.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?
Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued.
The current stock price of €143.90 is trading 15.2% above its estimated GF Value™ of €124.86.
Key valuation signals for MIL:1CRL:
EBIT per Share: €-1.02
GF Value™: €124.86 vs. price of €143.90 (15.2% above fair value)
No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Charles River Laboratories International Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
69GF Score
Get the complete analysis for MIL:1CRL
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1CRL has been successfully added to your 
